Inventor
ZDUNEK DIETMAR
DE25 patents
⚠️ This page may combine multiple inventors who share the name “ZDUNEK DIETMAR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HESS GEORG
9 patentsUS8486706B2Jul 16, 2013
L-FABP, natriuretic peptides, and cardiac troponins in subjects in need of cardiac therapy
HESS GEORG5 citations72
US8501155B2Aug 6, 2013
Biochemical markers for acute pulmonary embolism
HESS GEORG2 citations61
US8771961B2Jul 8, 2014
Monitoring myocardial infarction and its treatment
HESS GEORG1 citations51
US8497095B2Jul 30, 2013
Biochemical markers for acute pulmonary embolism
HESS GEORG0 citations51
US8440463B2May 14, 2013
Predicting renal failure in diabetes patients based on placental growth factor and soluble FLT-1
HESS GEORG0 citations51
US8062857B1Nov 22, 2011
H-FABP as early predictor of myocardial infarction
HESS GEORG1 citations50
US9983213B2May 29, 2018
Identification of subjects being susceptible to anti-angiogenesis therapy
HESS GEORG0 citations40
US9638700B2May 2, 2017
NT-pro ANP and SFlt-1 for the differentiation between circulatory and ischemic events
HESS GEORG0 citations40
US8663941B2Mar 4, 2014
Method for diagnosing and monitoring cardiac ischemia in patients with acute chest pain and without myocardial infarction
HESS GEORG0 citations40
ROCHE DIAGNOSTICS OPERATIONS
6 patentsUS8003396B2Aug 23, 2011
NT-proBNP/troponin ratio for assessing myocardial dysfunction
ROCHE DIAGNOSTICS OPERATIONS7 citations83
US7651679B2Jan 26, 2010
Biochemical markers for acute pulmonary embolism
ROCHE DIAGNOSTICS OPERATIONS5 citations73
US8361800B2Jan 29, 2013
Diagnostic means and methods using troponin T and NT-proBNP
ROCHE DIAGNOSTICS OPERATIONS6 citations72
US8008083B2Aug 30, 2011
Natriuretic peptides for diagnosing cardiac complications due to coronary catheterization
ROCHE DIAGNOSTICS OPERATIONS1 citations51
US7955854B2Jun 7, 2011
Assessing heart failure in patients with atrial fibrillation using GDF-15 and natriuretic peptides
ROCHE DIAGNOSTICS OPERATIONS1 citations51
US7977105B2Jul 12, 2011
Myoglobin as early predictor of myocardial infarction
ROCHE DIAGNOSTICS OPERATIONS0 citations50
BOEHRINGER MANNHEIM GMBH
5 patentsUS5858803AJan 12, 1999
Process and reagent for the determination of a specifically bindable substance
BOEHRINGER MANNHEIM GMBH23 citations92
US5362655ANov 8, 1994
Process for the determination of a specifically bindable substance
BOEHRINGER MANNHEIM GMBH23 citations92
US5219764AJun 15, 1993
Hapten-biotin conjugates and their use
BOEHRINGER MANNHEIM GMBH19 citations82
US5164321ANov 17, 1992
Process for the removal of non-specific turbidities
BOEHRINGER MANNHEIM GMBH7 citations69
US5254677AOct 19, 1993
β-galactosidase substrates for cedia
BOEHRINGER MANNHEIM GMBH10 citations68
ROCHE DIAGNOSTICS OPERATIONS INC
5 patentsUS10942175B2Mar 9, 2021
Use of biomarkers in the assessment of the early transition from arterial hypertension to heart failure
ROCHE DIAGNOSTICS OPERATIONS INC1 citations57
US11719710B2Aug 8, 2023
GDF-15 and/or troponin T for predicting kidney failure in heart surgery patients
ROCHE DIAGNOSTICS OPERATIONS INC0 citations51
US11047865B2Jun 29, 2021
Troponin and BNP based diagnosis of risk patients and cause of stroke
ROCHE DIAGNOSTICS OPERATIONS INC0 citations51
US10732188B2Aug 4, 2020
NT-proANP and NT-proBNP for the diagnosis of stroke
ROCHE DIAGNOSTICS OPERATIONS INC0 citations41
US9535073B2Jan 3, 2017
Prediction and recognition of acute kidney injury after surgery
ROCHE DIAGNOSTICS OPERATIONS INC0 citations41